OTC:MGROF

MustGrow Biologics (MGROF) Stock Price, News & Analysis

C$0.74
-0.05 (-6.33%)
(As of 04/26/2024 ET)
Today's Range
C$0.73
C$0.81
50-Day Range
C$0.74
C$1.04
52-Week Range
C$0.57
C$1.81
Volume
212,536 shs
Average Volume
6,820 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MGROF stock logo

About MustGrow Biologics Stock (OTC:MGROF)

MustGrow Biologics Corp., an agricultural biotech company, focuses on development and commercialization of natural biopesticides, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops; and TerraMG, a mustard-derived soil biopesticide technology for use as a preplant soil biopesticide for soil-borne diseases and pests for various crops, such as fruits & vegetables, bananas, canola, and pulses. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

MGROF Stock Price History

MGROF Stock News Headlines

MustGrow Biologics (OTC:MGROF) Shares Down 5.1%
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
MustGrow Biologics Corp. (MGROF)
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
AbCellera Biologics Inc Ordinary Shares ABCL
See More Headlines
Receive MGROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MustGrow Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Agricultural Inputs
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Corey J. Giasson B.Sc. (Age 46)
    MBA, President, CEO & Director
    Comp: $212.04k
  • Mr. Todd L. Lahti CA (Age 58)
    CFA, CFO & Corporate Secretary
    Comp: $194.37k
  • Mr. Colin Bletsky
    COO & Director

MGROF Stock Analysis - Frequently Asked Questions

How have MGROF shares performed in 2024?

MustGrow Biologics' stock was trading at C$0.97 at the beginning of the year. Since then, MGROF shares have decreased by 23.7% and is now trading at C$0.74.
View the best growth stocks for 2024 here
.

How do I buy shares of MustGrow Biologics?

Shares of MGROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:MGROF) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners